Skip to main content
High RiskFDAfda-F-0046-2023OTHER

Nick's Krispi Nougat Protein Bar, 1.76 oz., in foil wrapper in 12 pack boxes. UPC: 00850009682345 Product of North Macedonia Distributed ...

Category
Units Affected
61
Recall Date
October 10, 2022
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2023.

Nick's Krispi Nougat Protein Bar is being recalled due to containing hazelnuts, which is not declared on the label.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2023.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Luthman Backlund Foods Usa Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0046-2023.

LUTHMAN BACKLUND FOODS USA INC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Luthman Backlund Foods Usa Inc Recall FAQ

Luthman Backlund Foods Usa Inc is the subject of a food safety report: Nick's Krispi Nougat Protein Bar, 1.76 oz., in foil wrapper in 12 pack boxes. UPC: 00850009682345 Product of North Macedonia Distributed .... The notice was published on October 10, 2022 by the U.S. Food and Drug Administration (FDA). Approximately 61 units are potentially affected.